Coronavirus: All the Details About Johnson & Johnson Vaccine
The race to find an effective vaccine to combat Covid-19 has led the world to find three. Yet, the struggle remained, with shortages of supplies and logistics slowing down everything. In such grim circumstances, the news of the Johnson & Johnson vaccine getting approved by the FDA brought a long cheer in some quarters in both Florida, America and around the world.
So, let’s find out the details about the coronavirus vaccine made by Johnson & Johnson below.
Single-Shot Vaccine by Johnson & Johnson
Johnson & Johnson got authorised by the FDA for their Janssen COVID-19 Vaccine. It’s a single-shot vaccine with an 85% efficacy rate in preventing serious illness. If all other cases are included, the efficacy rate comes down to 66%.
People in Florida and all across America celebrated the news, although the US government was already meeting their vaccine distribution goals. It’s great news for other nations too, as the UK, EU, Canada, and Covax nations have ordered 30 million, 200 million, 38 million, and 500 million doses respectively.
Why is the Johnson & Johnson Vaccine a Game Changer?
The best thing about the Johnson & Johnson vaccine is that it’s a single-shot dose, unlike others that required two doses within a short period. It not only makes the vaccine doses available to more people but also trims down the workload of the vaccine administering workers.
The jab is also easier to transport and store, making it an even more appealing proposition in the combat against the coronavirus. If stored at −20 °C, it can remain stable for two years. Stored between 2 to 8 °C, it would remain effective for three months. The Janssen Single-shot vaccine can also be kept at a normal temperature of up to 25 °C for 12 hours, which makes it so much better for distribution.